logo

For the Inventor, By the Inventor

Danville, CA, United States of America

Jiping Fu

USPTO Granted Patents = 35 

 

Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 96(Granted Patents)


Location History:

  • Cambridge, MA (US) (2012)
  • Arlington, MA (US) (2010 - 2013)
  • Lafayette, CA (US) (2012 - 2015)
  • Wilmington, DE (US) (2022)
  • Danville, CA (US) (2015 - 2024)

Company Filing History:

goldMedal21 out of 3,923 
 
Novartis Ag
 patents
silverMedal14 out of 15 
 
Nikang Therapeutics, Inc.
 patents

Years Active: 2010-2025

Loading Chart...
Loading Chart...
35 patents (USPTO):Explore Patents
1. 12435034 - Process of preparing 3-fluoro-5(((1R,2AR)-3,3,4,4-tetrafluoro-1,2A-dihydroxy-2,2A,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)-oxy)benzonitrile (2025-10-07),
2. 12415779 - Processes of making 3-fluoro-5-(((1S,2aR)-1,3,3,4,4-pentafluoro-2a-hydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)oxy)-benzonitrile and polymorphs thereof (2025-09-16),
3. 12391642 - Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors (2025-08-19),
4. 12264167 - Fused tricyclic ring derivatives as SRC homology-2 phosphate inhibitors (2025-04-01),
5. 12171741 - 2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors (2024-12-24),
6. 12077506 - Indane derivatives as hypoxia inducible factor-2(α) inhibitors (2024-09-03),
7. 11753366 - Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors (2023-09-12),
8. 11634382 - Process of preparing 3-fluoro-5(((1R,2aR)-3,3,4,4-tetrafluoro-1,2a-dihydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)-oxy)benzonitrile (2023-04-25),
9. 11518772 - Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors (2022-12-06),
10. 11459340 - Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors (2022-10-04),
11. 11420936 - Hypoxia inducible factor-2(alpha) inhibitors and their use in the treatment of diseases (2022-08-23),
12. 11267782 - Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2α inhibitors (2022-03-08),
13. 11234977 - Fused tricyclic pyrazolo-dihydropyrazinyl-pyridone compounds as antivirals (2022-02-01),
14. 11034705 - Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors (2021-06-15),
15. 10975078 - Fused indazole pyridone compounds as antivirals (2021-04-13),

Certainly! Here is the article about inventor Jiping Fu:

Title: Jiping Fu: Pioneering Innovation in the World of Patents

Introduction:

Jiping Fu, a visionary inventor based in Danville, California (US), has made significant contributions to the field of patents and inventions. With a passion for innovation and a relentless drive to push technological boundaries, he has solidified his reputation as a pioneering figure in this ever-evolving industry.

Latest Patents:

Among his impressive portfolio of 29 patents, Jiping Fu's latest groundbreaking inventions include tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia-inducible factor-2(alpha) inhibitors. These compounds have shown promise in the treatment of diseases treatable by the inhibition of HIF-2(alpha). Additionally, he has developed a process for preparing 3-fluoro-5-(((1R,2aR)-3,3,4,4-tetrafluoro-1,2a-dihydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)-oxy)benzonitrile, which holds great potential in the pharmaceutical industry.

Career Highlights:

Throughout his career, Jiping Fu has showcased a remarkable ability to innovate and create novel solutions. Having worked with esteemed companies such as Novartis AG and Nikang Therapeutics, Inc., he has honed his skills and expertise in the development of cutting-edge technologies that have the potential to transform industries.

Collaborations:

Jiping Fu has had the privilege of collaborating with talented individuals in his field, including coworkers Subramanian Karur and Peichao Lu. Their collective efforts have led to the successful realization of innovative concepts and the creation of impactful patent applications.

Conclusion:

In conclusion, Jiping Fu's relentless pursuit of innovation, coupled with his remarkable contributions to the field of patents and inventions, has established him as a trailblazing inventor in the industry. His dedication to pushing technological boundaries and creating solutions that address critical needs underscores his passion for driving positive change through innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…